Search for: "Allergan, Inc." Results 281 - 300 of 385
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Sep 2017, 12:22 pm by Mark Astarita
Calamari’s tenure as Regional Director, the New York office has brought many significant enforcement actions, including charges against:National audit firm BDO USA for dismissing red flags and issuing false and misleading unqualified audit opinions about the financial statements of staffing services company General Employment Enterprises           Pharmaceutical company Allergan Inc. for disclosure failures in the wake of… [read post]
21 Oct 2021, 9:50 am by Simmons Hanly Conroy
For more details on any of the previous weeks in the New York opioid trial, visit past coverage: New York Opioid Trial Begins With Opening Arguments “Gremlins” Analogy Nets National Headlines New York Agrees to $1.18 Billion Settlement With Three Major Distributors Local Officials, First Responders Testify in New York Opioid Trial New York State Files Motion for Default Judgment Endo Pharmaceuticals Agrees to Settlement Remaining defendants in the trial include Teva Pharmaceuticals USA,… [read post]
16 May 2011, 11:51 am
Allergan, Inc. will appear at CCH Advertising Law Guide ¶64,274. [read post]
16 Sep 2021, 12:57 pm by Simmons Hanly Conroy
” The New York State trial is expected to continue into October with remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
20 Jun 2012, 12:38 pm by Edward M. McNally
The complaints alleged that the board of directors of Allergan Inc. was liable for failing to prevent Allergan from improperly marketing its Botox drug and thereby incurring a massive fine for doing so. [read post]
27 Jul 2018, 6:00 am by Kyle Kroll
Mylan Pharmaceuticals, Inc., 18-1638 (Fed. [read post]
27 Jul 2018, 6:00 am by Kyle Kroll
Mylan Pharmaceuticals, Inc., 18-1638 (Fed. [read post]
25 Oct 2010, 10:22 am by Stefanie Levine
Patent No. 7,405,203 owned by Allergan, Inc. and entitled PHARMACEUTICAL COMPOSITIONS INCLUDING LOW DOSAGES OF DESMOPRESSIN. [read post]
1 Apr 2014, 7:17 pm
     Procedural HistoryPlaintiffs- Appellants Senju Pharmaceutical Co., Ltd., Kyorin Phar- maceutical Co., Ltd., and Allergan, Inc. [read post]
18 Jul 2012, 11:03 pm by FDABlog HPM
Allergan Inc., is a qui tam alleging federal and state false claims action violations arising out of average manufacturer price (“AMP”) reporting. [read post]
22 Mar 2010, 10:22 am by Michael
Representatives from Allergan, Inc., the manufacturers of Botox, did not offer any comment on either cases. [read post]